Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/26/1992 | CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures |
11/26/1992 | CA2109603A1 Stealth virus detection in the chronic fatigue syndrome |
11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
11/26/1992 | CA2109503A1 Galanin antagonist |
11/26/1992 | CA2108754A1 Endothelin antagonists |
11/26/1992 | CA2108549A1 Plant defense gene(s) and regulatory element(s) |
11/26/1992 | CA2103376A1 Purification and cloning of p62 |
11/26/1992 | CA2103161A1 D-type cyclin and uses related thereto |
11/26/1992 | CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof |
11/26/1992 | CA2102195A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
11/26/1992 | CA2087339A1 Dictyostelid expression vector and method for expressing a desired protein |
11/26/1992 | CA2086676A1 Grf analogs xi |
11/26/1992 | CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily |
11/26/1992 | CA2083272A1 Novel antipathogenic peptides and compositions containing same |
11/25/1992 | EP0515313A2 Somatostatin analogues containing chelating groups and their radiolabeled compositions |
11/25/1992 | EP0515235A2 DNA sequences coding for protein components of african horsesickness virus |
11/25/1992 | EP0515228A2 Essential pure human parathyroid hormone |
11/25/1992 | EP0514970A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers |
11/25/1992 | EP0514830A2 Methods and compositions of a preparation and use of a herpes protease |
11/25/1992 | EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use |
11/25/1992 | EP0514488A1 Retinoid receptor compositions and methods |
11/25/1992 | EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof |
11/25/1992 | EP0514475A1 CYCLIC GnRH ANTAGONISTS |
11/25/1992 | EP0514464A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
11/25/1992 | EP0514458A1 Assays and treatments for autoimmune diseases |
11/25/1992 | EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19. |
11/25/1992 | EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites |
11/25/1992 | EP0416032A4 Agrichemical screens |
11/25/1992 | EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes |
11/25/1992 | EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
11/25/1992 | CN1066470A Process for producing monocyte chemotactic factor polypeptide and train for production thereof |
11/25/1992 | CA2331239A1 Structure, production and use of heregulin |
11/25/1992 | CA2069027A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers |
11/24/1992 | US5166329 Genetic engineering; mutants |
11/24/1992 | US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof |
11/24/1992 | US5166321 Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
11/24/1992 | US5166319 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
11/24/1992 | US5166318 Anticoagulants |
11/24/1992 | US5166317 Neurotrophic factor |
11/24/1992 | US5166316 Polypeptides for genetic engineering |
11/24/1992 | US5166195 Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
11/24/1992 | US5166191 Hormones for cardiovascular disorders |
11/24/1992 | US5166133 Antideposit agents or antiinflammatory agents by administering microglobulins |
11/24/1992 | US5166066 Gamma-aminobutyric acid as neurotransmitters |
11/24/1992 | US5166063 Immobolization of biomolecules by enhanced electrophoretic precipitation |
11/24/1992 | US5166059 Genetic engineering to correct gene defects |
11/24/1992 | US5166058 Proteins for treatment of bone and cartilage defects for wound healing and tissue repair |
11/24/1992 | US5166057 Templates for gene expression |
11/24/1992 | US5166056 Recombinant trichosanthin and coding sequence |
11/24/1992 | US5166050 Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
11/24/1992 | US5165931 Peptifluorin and neopeptifluorin |
11/24/1992 | US5165927 Cysteine modified to reduce ADP-ribosyl transferase activity |
11/24/1992 | US5165925 Vaccine for immunizing fish against infectious pancreatic necrosis virus |
11/24/1992 | CA1310794C Derivatives of bicyclic amino acids, a process for their preparation, agents containing them and their use |
11/24/1992 | CA1310793C Nor-statine and nor-cyclostatine polypeptides |
11/24/1992 | CA1310602C Yeast promoter and process for preparing heterologous protein |
11/24/1992 | CA1310601C Expression vectors |
11/23/1992 | CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use |
11/21/1992 | CA2102292A1 The astrovirus human gastroenteritis agents and molecular cloning of corresponding cdnas |
11/19/1992 | EP0514361A1 Galanin antagonist |
11/19/1992 | EP0514210A2 GRF analogs |
11/19/1992 | EP0514207A2 Novel human neurokinin-1 receptor short form |
11/19/1992 | EP0514173A2 Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase |
11/19/1992 | EP0513921A2 Recombinant vaccine against Marek's disease |
11/19/1992 | EP0513849A2 Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells |
11/19/1992 | EP0513675A1 New peptide compound and a process for the preparation thereof |
11/19/1992 | EP0513613A1 Novel polypeptides with affinity to lipopolysaccharides and their uses |
11/19/1992 | EP0513388A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor |
11/19/1992 | EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
11/19/1992 | EP0513345A1 Therapeutic and diagnostic applications of fetal fibronectin |
11/19/1992 | EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications |
11/19/1992 | EP0513334A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-$g(b) FOR BONE REPAIR |
11/19/1992 | EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof |
11/19/1992 | EP0513203A1 Diagnosis of hereditary retinal degenerative diseases |
11/19/1992 | EP0513201A1 Leukocyte-derived growth factor |
11/19/1992 | EP0513150A1 New method for treating immunodeficiency or neutropenia |
11/19/1992 | EP0513116A1 Self-inactivating bird vector |
11/19/1992 | EP0513090A1 Hepatitis a vaccines |
11/19/1992 | EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES. |
11/19/1992 | EP0513054A1 Virus/herbicide resistance genes process for producing same and their use |
11/19/1992 | EP0477290A4 Methods, compositions and devices for growing cells |
11/19/1992 | DE4116256A1 Measurement of allele-specific peptide sequences from class I or II MHC |
11/18/1992 | WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
11/18/1992 | CN1066272A Process for preparation of anti-thrombin polypeptides |
11/18/1992 | CN1066193A Recursor form of boving growth hormone releasing factor and related dna compounds |
11/18/1992 | CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth |
11/18/1992 | CA2068372A1 Human neurokinin-1 receptor short form |
11/17/1992 | WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
11/17/1992 | US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer |
11/17/1992 | US5164485 Modified hepatitis B virus surface antigen P31 and production thereof |
11/17/1992 | US5164483 Y-carboxyglutamate derivative, method for preparing the same and method for preparing human osteocalcin using the same |
11/17/1992 | US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof |
11/17/1992 | US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
11/17/1992 | US5164371 Inhibitors of human leukocytic elastase |
11/17/1992 | US5164370 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
11/17/1992 | US5164369 Asparagine, leucine, arginine, cysteine |
11/17/1992 | US5164366 Diabetes |
11/17/1992 | US5164317 Method for enhanced growth and proliferation of mast cells |
11/17/1992 | US5164315 Basic protein phospholiphase A2 |
11/17/1992 | US5164313 Recombinant vaccinia virus encoding cytochromes P-450 |